Action of 6-hydroxy-6-methyl-2-amino-heptane (hepatminol) in chronic cor pulmonale and myocardiosclerosis
Puleo, F.
Minerva Cardioangiologica 19(10): 525-530
1971
ISSN/ISBN: 0026-4725 PMID: 5098891 Document Number: 34911
Document emailed within 1 workday
Related Documents
Moron, J.; Rautureau, M.; Huel, C.; Pierré, A.; Berthier, L.K.; Atassi, G.; Bisagni, E. 1993: Synthesis and evaluation of 4-amino-substituted 7-methoxy (and 7-hydroxy)- 11-methyl (and 5,11-dimethyl)-10H-pyrido [2,3-b] carbazoles and 4-amino- substituted 11-methyl (and 5,11-dimethyl)-10H-pyrido[3',4':4,5] pyrrolo [3,2-g] quinolines, two new series related to antitumor ellipticine derivatives Anti-Cancer Drug Design 8(6): 399-416Malizia, E.; Pietropaoli, P.; Signore, L. 1970: Use of tris-hydroxy-methyl-amino methane in acid-base changes in resuscitation La Clinica Terapeutica 53(5): 405-429
Oja, S.S.; Janáky, R.; Saransaari, P.; Jenei, Z.; Varga, V. 1995: Interaction of glutathione derivatives with brain 2-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptors Proceedings of the Western Pharmacology Society 38: 9-11
Gill, R. 1994: The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia Cerebrovascular and Brain Metabolism Reviews 6(3): 225-256
Melegari, M.; Raffa, L.; Vampa, G. 1970: Research in the field of 1,2-4-benzothiadiazine. XLVI. Action of methyl sulfates on 3-amino-1,2,4-benzothiadiazine-1,1-dioxide and on its N2-methyl derivative Il Farmaco; Edizione Scientifica 25(12): 953-960
Tsatsas, G.; Siatra, T.; Varonos, D.; Spyraki, C. 1973: O,m,p-(2-Hydroxy-(mono- or disubstituted)-3-amino) propoxybenzoic acid esters and their pharmacologic action Annales Pharmaceutiques Francaises 31(4): 305-312
Hashimoto, Y.; Shudo, K.; Imamura, M.; Okamoto, T. 1980: Reactions of potent mutagens, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) and 2-amino-6-methyl-dipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1) with nucleic acid Nucleic Acids Symposium Series 8: S109-S112
Desai, M.A.; Burnett, J.P.; Ornstein, P.L.; Schoepp, D.D. 1995: Cyclothiazide acts at a site on the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor complex that does not recognize competitive or noncompetitive AMPA receptor antagonists Journal of Pharmacology and Experimental Therapeutics 272(1): 38-43
Takeda, M.; Takagi, T. 1980: Effects of a new bronchodilator, (alpha RS)-3-formamido-4-hydroxy-alpha-[[[(alpha RS)-p-methoxy-alpha-methylphenethyl] amino] methyl] benzyl alcohol fumarate dihydrate (BD 40A) on gastric acid secretion and gastrointestinal motility Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(3): 185-191
Kossakowski, J.; Zawadowski, T.; Kuśmierczyk, J. 1998: Synthesis of new N-[4-(4-aryl- and 4-heteroaryl-1-piperazinyl)butyl]derivatives of 1-methyl-5-oxobicyclo[2.2.1]heptane-2,3-dicarboximide with an expected anxiolytic activity Acta Poloniae Pharmaceutica 55(4): 315-318
Chachaj, W.; Cieślińska, A.; Kuczyńska-Sekieta, K.; Wrzeszcz, M. 1972: Effect of dihydrobenzperidol on urinary excretion of 17-hydroxycorticosteroids, 3-methyl-4-hydroxymandelic acid 5-hydroxy-indoleacetic acid and uropepsin in patients with chronic gastric and duodenal ulcer Polski Tygodnik Lekarski 27(41): 1596-1598
Zalewska, A.; Winnicka, M.M.; Wiśniewski, K. 1996: Psychotropic activity of N-methyl-2-amino-4-phosphonobutyric acid (N-methyl AP4) Polish Journal of Pharmacology 48(4): 415-423
Mineura, K.; Mori, T.; Katakura, R.; Sasaki, T. 1981: Therapeutic effects of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) and radiation on the rat glioma No Shinkei Geka. Neurological Surgery 9(3): 257-265
Gini, R. 1971: Treatment of chronic bronchopulmonary diseases with a N-(2-amino-3,5-dibromobenzyl-N-methyl-N-cyclohexl-ammonium chloride and benzidamine chlorohydrate combination Prensa Medica Argentina 58(13): 673-676
Shimizu, K.; Ushio, Y.; Hayakawa, T.; Mogami, H. 1980: Combination chemotherapy with 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride and bleomycin in meningeal carcinomatosis in rats Cancer Research 40(4): 1341-1343
Fukuda, K.; Shindo, H.; Shimizu, F.; Arakawa, M.; Mizuhira, V. 1980: Ultrastructral changes induced by 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea in L1210 lymphocytic leukemia cells in mice Cancer Research 40(1): 133-138
Lardy, C.; Rousselot, C.; Chavernac, G.; Depin, J.C.; Guerrier, D. 1994: Antiaggregant and antivasospastic properties of the new thromboxane A2 receptor antagonist sodium 4-[[1-[[[(4-chlorophenyl)sulfonyl]amino]methyl]cyclopentyl] methyl]benzeneacetate Arzneimittel-Forschung 44(11): 1196-1202
Fujimoto, S.; Ogawa, M.; Hoshino, A. 1980: Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites Gan 71(1): 60-72
Gemba, T.; Ninomiya, M.; Matsunaga, K.; Ueda, M. 1993: Effects of a novel calcium antagonist, S-(+)-methyl-4,7-dihydro-3-isobutyl-6- methyl-4-(3-nitrophenyl)thieno[2,3-b]pyridine-5-carboxylate (S-312-d), on ischemic amino acid release and neuronal injury in stroke-prone spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics 265(1): 463-467
Hallak, M.; Irtenkauf, S.M.; Cotton, D.B. 1996: Effect of magnesium sulfate on excitatory amino acid receptors in the rat brain. II. Kainate and alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors American Journal of Obstetrics and Gynecology 175(3 Pt 1): 582-587